Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Duchenne muscular dystrophy.

J R Gorospe1, E P Hoffman

  • 1Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, PA 15261.

Current Opinion in Rheumatology
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Recent genetic discoveries for Duchenne muscular dystrophy (DMD) have accelerated molecular diagnostics. Current research focuses on dystrophin biochemistry and the effects of its deficiency.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA.

Neuromuscular disorders : NMD·2017
Same author

Mosaic focal dermal hypoplasia caused by a novel somatic mutation in PORCN detected in affected skin.

The British journal of dermatology·2015
Same author

Leptin and leptin receptor genetic variants associate with habitual physical activity and the arm body composition response to resistance training.

Gene·2012
Same author

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for treatment.

Neurology·2011
Same author

GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Neurology·2011
Same author

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.

Neurology·2010
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Genetics
  • Biochemistry
  • Molecular Biology

Background:

  • Duchenne muscular dystrophy (DMD) is a severe genetic disorder.
  • Recent advances have improved understanding of DMD's genetic underpinnings.

Purpose of the Study:

  • To summarize recent progress in DMD molecular diagnostics.
  • To highlight current research directions in dystrophin biochemistry and pathophysiology.

Main Methods:

  • Review of recent genetic research in DMD.
  • Analysis of emerging data on dystrophin function and deficiency.

Main Results:

  • Rapid implementation of molecular diagnostics for DMD.
  • Growing knowledge of dystrophin's biochemical role and disease consequences.

Conclusions:

  • Genetic insights have revolutionized DMD diagnostics.
  • Further research into dystrophin is crucial for understanding DMD's pathology.